Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128575) titled 'Effect of an Oral Methylprednisolone and Sequential Telitacicept Regimen in Patients with IgA Nephropathy: The MASTER-IgAN Real-World Study' on July 22.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The 2nd Affiliated Hospital of Chongqing Medical University
Condition:
IgA Nephropathy
Intervention:
Glucocorticoid Monotherapy Group:None
Corticosteroid Sequential Telitacicept Regimen Group:None
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-07-25
Target Sample Size: Glucocorticoid Monotherapy Group:60;Corticosteroid Sequential Telitacicept Reg...